Raju Mohan
Gründer bei VENTYX BIOSCIENCES, INC.
Vermögen: 8 Mio $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Somu Subramaniam | M | 69 |
New Science Ventures LLC
 New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London.
Escalier Biosciences BV
 Escalier Biosciences BV BiotechnologyHealth Technology Escalier Biosciences BV develops biological products. The company is headquartered in Nijmegen, the Netherlands.
Vimalan Biosciences, Inc.
| 20 Jahre |
| Christopher Krueger | M | 56 |
Akarna Therapeutics Ltd.
 Akarna Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Akarna Therapeutics Ltd. develops novel small molecule therapeutics. It offers non-bile acid FXR agonist, a therapeutic for the treatment of nonalcoholic steatohepatitis and fatty-liver diseases. The company was founded by Raju Mohan in 2014 and is headquartered in Cambridge, the United Kingdom.
Escalier Biosciences BV
Escalier Biosciences BV BiotechnologyHealth Technology Escalier Biosciences BV develops biological products. The company is headquartered in Nijmegen, the Netherlands.
Vimalan Biosciences, Inc.
X-Ceptor Therapeutics, Inc.
 X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents | 13 Jahre |
| John Nuss | M | 65 |
Vimalan Biosciences, Inc.
Escalier Biosciences BV
Escalier Biosciences BV BiotechnologyHealth Technology Escalier Biosciences BV develops biological products. The company is headquartered in Nijmegen, the Netherlands. | 7 Jahre |
| Onaiza Cadoret-Manier | F | 60 | 1 Jahre | |
| Brenda Marex | F | - |
New Science Ventures LLC
New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London. | 14 Jahre |
| Tom J. A. Lavin | M | - |
New Science Ventures LLC
New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London. | 20 Jahre |
| William White | M | 51 | 3 Jahre | |
| Andrew Abrams | M | - |
New Science Ventures LLC
New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London. | 8 Jahre |
| Norman Selby | M | 71 |
Oppilan Pharma Ltd.
 Oppilan Pharma Ltd. BiotechnologyHealth Technology Oppilan Pharma Ltd. operates as a biotechnology company. The company is headquartered in Cambridge, the United Kingdom.
Escalier Biosciences BV
Escalier Biosciences BV BiotechnologyHealth Technology Escalier Biosciences BV develops biological products. The company is headquartered in Nijmegen, the Netherlands. | 8 Jahre |
| Allison Hulme | M | 61 | 1 Jahre | |
| Patrick Haley | M | 48 | 14 Jahre | |
| John L. Cecil | M | 70 |
New Science Ventures LLC
New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London. | 10 Jahre |
| Sheila Gujrathi | M | 53 | 3 Jahre | |
| Jean-Pierre Bizet | M | 76 |
New Science Ventures LLC
New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London. | 9 Jahre |
| Edward van Wezel | M | - |
Escalier Biosciences BV
Escalier Biosciences BV BiotechnologyHealth Technology Escalier Biosciences BV develops biological products. The company is headquartered in Nijmegen, the Netherlands. | - |
| Martin Auster | M | 49 | 3 Jahre | |
| Jonny He | M | - |
New Science Ventures LLC
New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London. | 8 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jennifer Drimmer | F | - | 14 Jahre | |
| William Sandborn | M | 61 | 1 Jahre | |
| Christoph Pereira | M | 51 | 3 Jahre | |
| Carl Feldbaum | M | 80 | 16 Jahre | |
| Richard Gaster | M | 40 | 2 Jahre | |
| Richard Heyman | M | 66 |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents | 7 Jahre |
| Jigar Choksey | M | 38 | 2 Jahre | |
| James Bucher | M | 59 | 7 Jahre | |
| Aaron Royston | M | 40 | 2 Jahre | |
| Scott Brown | M | 43 | 2 Jahre | |
| Jörn Drappa | M | 60 | 1 Jahre | |
| Natalie Sacks | M | 59 | 2 Jahre | |
| Ronald Shazer | M | 56 | 2 Jahre | |
| Kanya Rajangam | M | 50 | 3 Jahre | |
| Jeffrey R. Latts | M | 76 | 6 Jahre | |
| Rekha Hemrajani | F | 54 | 8 Jahre | |
| Patrick Rivers | M | - | 2 Jahre | |
| Leone Patterson | F | 61 | 3 Jahre | |
| Jeff P. Coon | M | 61 | 1 Jahre | |
| S. Michael Imperiale | M | - | 2 Jahre | |
| Anne Champsaur | M | - | - | |
| Arthur P. DeCillis | M | 68 | 8 Jahre | |
| Lloyd Appel | M | - |
New Science Ventures LLC
New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London. | 3 Jahre |
| Jason Hong | M | - |
Oppilan Pharma Ltd.
Oppilan Pharma Ltd. BiotechnologyHealth Technology Oppilan Pharma Ltd. operates as a biotechnology company. The company is headquartered in Cambridge, the United Kingdom. | - |
| Vivek Mohindra | M | 55 |
New Science Ventures LLC
New Science Ventures LLC Investment ManagersFinance New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London. | - |
| Larry Mattheakis | M | 67 | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 40 | 93,02% |
| Niederlande | 5 | 11,63% |
| Vereinigtes Königreich | 3 | 6,98% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Raju Mohan
- Persönliches Netzwerk